Bayesian Capital Management, LP Alphatec Holdings, Inc. Transaction History

Bayesian Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$9.49 - $14.26 $148,993 - $223,882	-15,700 Reduced 58.15%	11,300 $118,000
Q1 2024 May 15, 2024	BUY	$12.8 - $16.78 $18,457 - $24,196	1,442 Added 5.64%	27,000 $372,000
Q4 2023 Feb 14, 2024	BUY	$8.89 - $15.36 $227,210 - $392,570	25,558 New	25,558 $386,000
Q2 2023 Aug 14, 2023	BUY	$14.32 - $18.03 $249,168 - $313,722	17,400 New	17,400 $312,000
Q4 2022 Feb 14, 2023	BUY	$8.91 - $12.35 $192,144 - $266,327	21,565 New	21,565 $266,000
Q2 2022 Aug 15, 2022	BUY	$6.36 - $13.08 $118,932 - $244,596	18,700 New	18,700 $122,000

237

83.9M

250K

623K

Ticker ATEC
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 104,656,000
Market Cap $861M
Description
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; Sigma transforaminal lumbar interbody fusion pedic...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.